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Recently, two types of fatty acid synthases (FASs) have been discovered from apicomplexan parasites.
Although significant progress has been made in characterizing these apicomplexan FASs, virtually nothing was
previously known about the activation and regulation of these enzymes. In this study, we report the discovery
and characterization of two distinct types of phosphopantetheinyl transferase (PPTase) that are responsible
for synthesizing holo-acyl carrier protein (ACP) from three apicomplexan parasites: surfactin production
element (SFP) type in Cryptosporidium parvum (CpSFP-PPT), holo-ACP synthase (ACPS)-type in Plasmodium
falciparum (PfACPS-PPT), and both SFP and ACPS types in Toxoplasma gondii (TgSFP-PPT and TgACPS-
PPT). CpSFP-PPT and TgSFP-PPT are monofunctional, cytosolic, and phylogenetically related to animal
PPTases. However, PfACPS-PPT and TgACPS-PPT are bifunctional (fused with a metal-dependent hydrolase),
likely targeted to the apicoplast, and more closely related to proteobacterial PPTases. The function of api-
complexan PPTases has been confirmed by detailed functional analysis using recombinant CpSFP-PPT
expressed from an artificially synthesized gene with codon usage optimized for Escherichia coli. The recombi-
nant CpSFP-PPT was able to activate the ACP domains from the C. parvum type I FAS in vitro using either CoA
or acetyl-CoA as a substrate, or in vivo when coexpressed in bacteria, with kinetic characteristics typical of
PPTases. These observations suggest that the two types of fatty acid synthases in the Apicomplexa are activated
and regulated by two evolutionarily distinct PPTases.
Fatty acids are essential to all organisms, since they are one
of the major components in all biomembranes and are a com-
mon biological energy resource. The de novo biosynthesis of
fatty acids typically starts with the use of acetyl-coenzyme A
(CoA) as a precursor and malonyl-CoA as an extender with
repetitive addition of two-carbon units for chain elongation
(31, 36, 38, 39). Each fatty acyl two-carbon-unit elongation
consists of a series of biochemical reactions that are catalyzed
by different enzymes (e.g., malonyl/acyl transferase, acyl carrier
protein [ACP], ketoacyl synthase [KS], ketoacyl reductase, de-
hydrase, and enoyl reductase [ER]). In many organisms (e.g.,
humans, animals, and fungi), these enzymes are fused into one
or two multifunctional polypeptides, referred to as type I fatty
acid synthases (FASs) (36, 39). In other organisms (e.g., plants
and bacteria), these enzymes are discrete, monofunctional pro-
teins, referred to as type II FAS (23, 38). The synthesis of
polyketides resembles FAS, except that one or more reduction
and/or dehydration steps are ignored during chain elongation,
and different starters and extenders may be used, resulting in
the retaining of keto groups, hydroxyl moieties, double bonds,
and/or branched chains in final products (31, 37).
During fatty acid synthesis, the fatty acyl chain needs to be
attached to the holo-ACP at the prosthetic 4-phosphopanteth-
einyl moiety. However, newly synthesized ACP enzymes or
domains are apoproteins that lack the phosphopantetheinyl
moiety. The phosphopantetheinyl moiety is posttranslationally
transferred from CoA to a Ser residue in the ACP by a phos-
phopantetheinyl transferase (PPTase) (EC 2.7.8.7) (Fig. 1).
There are two major types of PPTases. The holo-ACP synthase
(ACPS)-type PPTases are typically specific to the type II FAS
or polyketide synthase (PKS) in bacteria, e.g., Escherichia coli
AcpS (21, 22). The surfactin production element (SFP)-type
enzymes are mostly specific to type I FAS, PKS, or nonribo-
somal peptide synthase, such as the Bacillus subtilis SFP, yeast
Lys5, and human PPTase (19, 26, 28, 30). The FAS -subunit
(FAS2) in fungi also contains an ACPS-type PPTase domain
and is sometimes referred to as a third type of PPTase (10, 27).
Fatty acid synthesis has been recently discovered for the
phylum Apicomplexa, which contains many important proto-
zoon parasites (e.g., Plasmodium, Babesia, Toxoplasma, Sarco-
systis, Cyclospora, Eimeria, and Cryptosporidium) (32, 40, 42, 44,
45). As a reflection of their divergent parasitic life styles, the
fatty acid metabolism is also diverse among apicomplexans.
For example, Plasmodium falciparum possesses only type II
enzymes that are targeted to the apicoplast for de novo fatty
acid synthesis (32, 41). However, Cryptosporidium parvum em-
ploys only a giant, 900-kDa type I FAS (CpFAS1) that is
capable of elongating medium- or long-chain fatty acids (42).
On the other hand, Toxoplasma gondii and Eimeria tenella
contain both type I and II enzymes and are able to synthesize
fatty acids de novo and elongate long chain fatty acids (44). In
addition, C. parvum also possesses a multifunctional polyketide
synthase (CpPKS1) that is not present in any other apicompl-
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exans examined so far (43). Currently, significant progress has
been made toward the molecular and functional characteriza-
tions of these two types of apicomplexan FASs. However,
nothing was known about the PPTases in this group of globally
important parasites. It was unclear whether the two distinct
apicomplexan ACP proteins were activated by different types
of PPTases. Because the synthesis of holo-ACP is essential for
fatty acid biosynthesis, PPTases may be considered as potential
drug targets in apicomplexans and other pathogens. In addi-
tion, we have previously expressed the C. parvum type I
CpFAS1 in bacteria. However, the ACP domains within re-
combinant CpFAS1 proteins were present in a nonfunctional
apo form. This prompted us to search for the C. parvum
PPTase that could specifically activate the CpFAS1 ACP do-
mains for functional and pharmaceutical exploration.
In this study, we have identified both SFP and ACPS types of
PPTases that may be responsible for activating type I and II
apicomplexan ACPs, respectively, from three major groups of
apicomplexans (i.e., P. falciparum, T. gondii, and C. parvum).
Bioinformatics analyses suggest that these two types of api-
complexan PPTases may have different evolutionary origins.
The SFP-type PPTases are more closely related to animal and
fungal PPTases, while the ACPS-type enzymes were probably
acquired from a proteobacterium. To further confirm the func-
tion of apicomplexan PPTases, we have also cloned and ex-
pressed the PPTase from C. parvum and detailed its enzymatic
features in activating recombinant CpFAS1 ACP domains. The
expression and protein localization of CpSFP-PPT have been
investigated using real-time PCR and immunofluorescence mi-
croscopy.
MATERIALS AND METHODS
Identification and phylogenetic analyses of PPT genes from the apicomplexan
genomes. Four apicomplexan PPTases were identified from three genome data-
bases by BLAST searches (P. falciparum [http://PlasmoDB.org], T. gondii [http:
//ToxoDB.org], and C. parvum [http://CryptoDB.org]) (5, 20, 29). One SFP-type
PPTase was found in C. parvum (CpSFP-PPT), whereas one ACPS type was
identified from P. falciparum (PfACPS-PPT). However, both SFP and ACPS
types coexist in T. gondii (TgSFP-PPT and TgACPS-PPT). (Note: for clarity, we
will use SFP-PPT and ACPS-PPT to refer to the SFP-type and ACPS-type
PPTases, respectively). For the CpSFP-PPT gene, the transcript was amplified
and cloned from C. parvum sporozoite total RNA by reverse-transcription PCR
(RT-PCR). A comparison between cDNA and genomic DNA (gDNA) se-
quences revealed that CpSFP-PPT contained two introns. For the TgSFP-PPT
gene, potential introns were identified with the guide of protein multiple align-
ments and nucleotide patterns at the intron-exon boundaries of previously an-
notated genes found in GenBank. The other two apicomplexan PPTases
(TgACPS-PPT and PfACPS-PPT) appear to be intronless.
Apicomplexan PPTases were used as queries to search protein databases,
including all nonredundant GenBank CDS translations plus RefSeq Proteins
plus PDB plus SwissProt plus PIR plus PRF at the National Center for Biotech-
nology Information using the PSI-BLAST program (http://www.ncbi.nlm.nih
.gov/BLAST/) (3). Four iterative PSI-BLAST searches were performed for each
protein (matrix  BLOSUM62; gap penalties: existence  11 and extension 
1). Only sequences with E-values lower than 1  104 were retrieved for further
analysis. Protein multiple sequence alignments were performed using a ClustalW
algorithm, and apparent mistakes in alignments were corrected based upon
visual inspections. Conserved motifs were determined from protein alignments
(see protein alignments in the supplemental material), and block logos were
derived from position-specific scoring matrices (PSSM) at the BLOCKS server
(http://blocks.fhcrc.org/blocks) (15).
Only amino acid positions that could be unambiguously aligned were selected
for phylogenetic analyses (see protein alignments in the supplemental material).
Maximum likelihood (ML) trees were constructed using the PROML program
distributed in the PHYLIP package (http://evolution.gs.washington.edu
/phylip.html). The JTT model of amino acid substitution (18) was used in ML
analysis with the consideration of among-site heterogeneity using the fraction of
invariance plus a four-rate -distribution model (JTT-f    Inv). Sequence
input orders were randomized with 10 jumps, and global rearrangements were
enabled during the tree searches. Missing parameters required by the PROML
program were estimated by the Tree-Puzzle v5.2 program (34). In addition, ML
trees were also reconstructed using a Bayesian inference method using the same
model of amino acid substitutions (i.e., JTT-f    Inv) (17). A total of 500,000
generations of searches were performed with four chains simultaneously running,
and the current trees were saved every 100 generations. Posterior probabilities at
tree nodes were obtained by calculating consensus trees from 4,000 Bayesian
inference trees written after the ML sums converged.
Gene expression pattern and protein localization of CpSFP-PPT in C. parvum.
The CpSFP-PPT gene expression pattern during the parasite complex life cycle
was analyzed by real-time quantitative RT-PCR (qRT-PCR). Total RNA was
isolated from different C. parvum (IOWA strain) life cycle stages (i.e., oocysts,
sporozoites, intracellular stages cultured in HCT-8 cells for 6, 12, 24, 36, 48, 60,
and 72 h) and uninfected host cells using an RNeasy isolation kit (QIAGEN) (7,
24). Since host cell RNA was present in intracellular samples, only the relative
level of CpSFP-PPT transcripts was determined in comparison to that of C.
parvum 18S rRNA for each sample. Real-time qRT-PCR analyses were per-
formed using the SYBR-green-based iScript One-Step RT-PCR kit (Bio-Rad)
and primers specific to CpSFP-PPT (301F, 5-TCG GAA AGT GAT TCA TTA
CTG C-3; and 421R, 5-CTC TGG AAG GTG ATA ACT CGG-3) and 18S
rRNA (995F, 5-TAG AGA TTG GAG GTT GTT CCT-3; and 1206R, 5-CTC
CAC CAA CTA AGA ACG GCC-3) (1), respectively. Reactions containing 20
ng of total RNA and 0.2 M specified primers were first incubated at 48°C for
30 min to synthesize cDNA, heated at 95°C for 15 min to inactivate reverse
transcriptase, and then subjected to 45 thermal cycles (95°C, 20 s; 50°C, 30 s; and
72°C, 30 s) of PCR amplification using an iCycler iQ real-time PCR detection
system (Bio-Rad). Each reaction contained at least three replicates. Under the
specified conditions and based on annealing curve analysis, each pair of primers
FIG. 1. PPTases synthesize holo-ACP by transferring the phosphopantetheinyl moiety from CoA to apo-ACP (A). The phosphopantetheinyl
moiety is attached to the Ser residue of ACP (B).
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produced only one amplicon from samples containing parasite RNA but no
products from total RNA isolated from uninfected host cells. Standard curves for
both pairs of primers were determined using serially diluted DNA templates in
real-time PCR analysis, followed by linear regression to determine needed pa-
rameters (curve slopes and intersections). Based on the standard curves, the
amounts of CpSFP-PPT transcripts and 18S rRNA in every sample were calcu-
lated. The level of CpSFP-PPT transcripts in each sample was then normalized
using that of 18S as a control (i.e., expressed as a ratio between levels of
CpSFP-PPT and 18S rRNA). Finally, the relative level of CpSFP-PPT transcripts
in each developmental stage was plotted relative to the mean level of all samples
(i.e., ratio between individual normalized level and the overall mean).
For producing polyclonal antibodies to CpSFP-PPT, a short peptide corre-
sponding to the CpSFP-PPT amino acid positions at 81 to 100 (CSPKQVKI
IREKGMKPYFKY) was synthesized, cross-linked to keyhole limpet hemocya-
nin, and used to immunize two pathogen-free rabbits three times according to
standard protocols at a commercial source (Alpha Diagnostic International).
The preimmune sera and antisera were evaluated using enzyme-linked immu-
nosorbent assay, immunofluorescence microscopy, and Western blot analysis to
determine their specificities and titers.
In Western blot analysis, C. parvum sporozoites were prepared by excystation
from fresh oocysts as previously described (24). Sporozoites were lysed in 1
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) buffer
containing 1 protease inhibitor cocktail (Sigma), fractionated by 10% SDS-
PAGE (	2  107 sporozoites/lane), and transferred to a nitrocellulose mem-
brane. Both rabbit preimmune serum and polyclonal antibody to CpSFP-PPT
(1:1,000 dilution) were incubated with membrane blots, which were in turn
detected with an Immuno-Star-AP chemiluminescent kit (Bio-Rad).
To detect CpSFP-PPT in parasite cells by immunofluorescence microscopy, C.
parvum sporozoites and intracellular stages infecting HCT-8 monolayers (cul-
tured on glass coverslips) were fixed in phosphate-buffered saline (PBS)-formalin
(10%), washed with PBS and water, extracted with cold methanol (20°C for 10
min) and 0.1% Triton X-100 (5 min, all at room temperature unless otherwise
specified), respectively, and blocked with 5% bovine serum albumin (BSA)-PBS.
Samples were then incubated with rabbit preimmune or antiserum (1:1,000
dilution) in 1% BSA-PBS, washed with PBS, and then incubated with a tetra-
methyl rhodamine isothiocyanate-labeled monoclonal antibody to rabbit immu-
noglobulin G (Sigma). Immunolabeled samples were mounted using a SlowFade
antifade medium containing 4,6-diamidino-2-phenylindole for DNA counter-
staining (Molecular Probes).
Expression of recombinant CpSFP-PPT and ACP domains. The CpSFP-PPT
gene was first cloned from parasite cDNA for expression in several commonly
used bacterial fusion systems (e.g., pET-based T7-tag, His-tag, and S-tag fu-
sions). However, either the expression was unsuccessful or the expression level
was too low to be useful for biochemical assays. The unsuccessful expression of
CpSFP-PPT was probably due to the extremely biased codon usages between the
AT-rich C. parvum and Escherichia coli genes. To overcome the difficulties in
protein expression, we used a PCR-based gene synthesis approach to reconstruct
an artificial CpSFP-PPT gene based on E. coli class II codon frequencies. Briefly,
a total number of 40 overlapping oligonucleotides (32 to 52 bases) were “reverse
translated” from the CpSFP-PPT protein sequence at the “DNAWorks” oligo-
nucleotide design server (http://molbio.info.nih.gov/dnaworks) (16). BamHI re-
striction sites were avoided in the synthetic gene but added to the 5 and 3 ends.
A two-step PCR approach was employed. The first PCR contained all 40 oligo-
nucleotides (0.2 M each), and a 15-cycle amplification by Pfu DNA polymerase
produced a smear of products. The second 20-cycle amplification step used the
outer two oligonucleotides (0.2 M) as primers and 1 l of product from the first
PCR as a template and yielded a single product. The synthetic gene was purified
from an agarose gel and cloned into the pCR-Blunt II-TOPO vector. After its
identity was confirmed by sequencing, the synthetic CpSFP-PPT gene was re-
leased by BamHI and inserted into the pET-29a vector with an S tag fused at the
N terminus. Expression of S-tag-fused CpSFP-PPT (S-CpSFP-PPT) protein was
carried out in a BL21(DE3) E. coli strain as recommended by the manufacturer
(Novagen). The S-CpSFP-PPT protein was purified from bacteria using an S-tag
thrombin purification kit, in which the fusion protein was isolated by S-protein
agarose columns and the “native” CpSFP-PPT portion was released from the
columns by digestion with thrombin.
The ACP domains within the loading unit (CpACP1) and elongation module
1 (CpACP2) of CpFAS1 were engineered into the pET24a (Novagen) and
pMAL-c2x (New England Biolabs) vectors, respectively, as previously reported
(44). The expression of T7-tag-fused CpACP1 (T7-CpACP1) or maltose-binding
protein (MBP)-fused CpACP2 (MBP-CpACP2) was carried out in E. coli Ro-
setta (DE3) or Rosetta strains. Recombinant T7-CpACP1 and MBP-CpACP2
were purified using a T7-tag affinity purification kit (Novagen) or an amylose
resin-based affinity purification kit (New England Biolabs), respectively.
Enzyme assays. The activity of recombinant CpSFP-PPT was assayed using
recombinant apo-T7-CpACP1 or apo-MBP-CpACP2 to receive the phospho-
pantetheinyl moiety from CoA or acetyl-CoA. Typical assay systems were per-
formed in 100 l Tris-HCl solution (75 mM; pH 7.0) containing MgCl2 (0.0039
to 20 mM), acetyl-CoA (0.39 to 200 M) (or CoA), apo-ACP (0.85 to 1 g), and
CpSFP-PPT (100 ng) at 37°C for specified time periods (19). After determining
that CpSFP-PPT could maintain linear activity for up to 20 min, we assayed the
enzyme kinetics with 10-min reactions using [1-14C]acetyl-CoA and MBP-
CpACP2 (5.0 M) as cosubstrates. Reactions were stopped by adding 1 ml
trichloroacetic acid (10%) and 25 l BSA (2%) as a protein carrier (13, 30).
Quenched reactions were incubated on ice for 5 min and centrifuged at 10,000
g for 10 min. Protein pellets were washed three times with 1 ml trichloroacetic
acid (10%), dissolved in 150 l formic acid, and transferred into 10 ml scintil-
lation cocktail (Sigma) for counting of radioactivity. For matrix-assisted laser
desorption ionization–time-of-flight (MALDI-TOF) mass spectrometry (MS),
reaction mixtures containing 0.1 mM acetyl-CoA (or CoA), 1 g T7-CpACP1,
and 1.0 mM MgCl2 were incubated for 30 min at 37°C, from which 20 l solution
from each reaction was removed for SDS-PAGE (20%) analysis, and the re-
maining 80 l solution was desalted with a Bio-Gel P-6DG resin (Bio-Rad) for
determining the Mr of T7-CpACP1 by MALDI-TOF MS. Reactions for autora-
diography followed similar procedures but used [1-14C]acetyl-CoA (0.1 mM) and
T7-CpACP1 or MBP-CpACP2 as substrates. Reactions were fractionated by
SDS-PAGE. The radioactivity from the CpSFP-PPT-transferred phospho-
pantetheinyl moiety on the T7-holo-CpACP1 or MBP-holo-CpACP2 was visu-
alized from dried gels using a FUJI BAS 1800 II PhosphorImager.
Activation of T7-CpACP1 by coexpression with CpSFP-PPT in bacteria. For
coexpression S-CpSFP-PPT and T7-CpACP1, we first isolated the pRIG-derived
pRARE plasmid from Rosetta bacteria (4) and prepared a blunt-ended plasmid
by PCR (primers: 5-ACT AGT AAC GGC CGC CAG TGT GC-3 and 5-AGT
GGA TCC GAG CTC GGT ACC AAG-3). Second, the S-CpSFP-PPT con-
struct, including the complete T7 promoter and transcriptional terminator, was
amplified from the pET29a-CpSFP-PPT vector (primers: 5-CTC CTT TCA
GCA AAA AAC CCC-3 and 5-CCC GCG AAA TTA ATA CGA CTC-3),
phosphorylated, and ligated into the linear pRARE vector. The resulting
pRARE-CpSFP-PPT construct and the pET24a-T7-CpACP1 vector were se-
quentially transformed into BL21(DE3) bacteria for coexpressing S-CpSFP-PPT
and T7-CpACP1 proteins. In the control experiments, T7-CpACP1 was coex-
pressed with plain pRARE vector only. T7-CpACP1 proteins coexpressed with
S-CpSFP-PPT or pRARE vector only were purified and desalted for the deter-
mination of their molecular masses by MALDI-TOF MS analysis.
Nucleotide sequence accession number. Nucleotide sequence data for the
CpSFP-PPT gene are available in the EMBL, GenBank, and DDJB databases
under the accession number AY856092.
RESULTS
Two types of PPTases coexist in the apicomplexan genomes.
By data mining the apicomplexan genome sequences, we have
discovered that apicomplexans possess both SFP-PPT and
ACPS-PPT genes in their genomes (Fig. 2; Table 1). However,
P. falciparum contains only an ACPS-PPT gene (PfACPS-
PPT), while C. parvum has only an SFP-PPT gene (CpSFP-
PPT). On the other hand, T. gondii possesses both an ACPS-
PPT and an SFP-PPT gene (TgACPS-PPT and TgSFP-PPT).
Whether an apicomplexan contains an ACPS-PPT and/or an
SFP-PPT gene is fully correlated with the type(s) of FAS/PKS
enzymes it possesses (Table 1). Apicomplexan ACPS-PPTs are
bifunctional enzymes containing a C-terminal PPTase domain
and an N-terminal metal-dependent hydrolase domain of yet-
undefined functions (Fig. 2). Such a hydrolase-PPTase fusion is
unique, since it has not yet been found in any other taxonomic
groups examined. PfACPS-PPT and TgACPS-PPT also con-
tain N-terminal transitional peptide sequences (Fig. 2; Table
1), suggesting that they are likely targeted to the apicoplast for
activating type II ACP. On the other hand, SFP-PPTs in C.
parvum and T. gondii are monofunctional enzymes that differ
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structurally from apicomplexan ACPS-PPTs. Both CpSFP-
PPT and TgSFP-PPT proteins are predicted to be cytosolic
(Table 1). In C. parvum (which lacks a plastid and type II FAS),
CpSFP-PPT may function in activating the multiple ACP do-
mains present in both type I CpFAS1 and CpPKS1 that have
been shown to be cytosolic (43, 45). However, the type I FAS
in T. gondii (TgFAS1) appears to be mainly localized to certain
regions of the network-like mitochondrion, particularly in the
region surrounding the apicoplast (8), which implies that the
activation of its ACP domains by TgSFP-PPT may likely occur
in the cytosol before TgFAS1 reaches the mitochondria.
Both SFP-PPT and ACPS-PPT from apicomplexans and
other organisms contain two conserved motifs as determined
by PSSM analysis of 312 sequences: [IV]G[ITV]D[ILV][VE]
and W[CA][AL]KEAxxK (Fig. 2). The universal conservative-
ness of these two motifs among all PPTases suggests that some
of their residues may be critical to the function of this family of
enzymes. In fact, this notion is supported by the recent point-
mutational analyses of PPTases in B. subtilis (11, 12). Besides
these two motifs, PSSM analyses also identified a motif
(FNxSH) present only among SFP-type PPTases (from 123
sequences) (Fig. 2). In addition, the identity of the hydrolase
domain in PfACPS-PPT and TgACPS-PPT was also supported
by their sequence similarity to other characterized metal-de-
pendent hydrolases and the presence of many conserved resi-
dues. The most conserved motif among this group of enzymes
is H[GSA]xLH[LM]x[GHE]xDH, in which the three H resi-
dues are present in almost all the hydrolase homologues ex-
amined here (from 50 sequences) (Fig. 2).
Different evolutionary origins of apicomplexan ACPS-PPT
and SFP-PPT. Although both SFP-PPT and ACPS-PPT are
present in the Apicomplexa or even within one species (e.g., T.
gondii), these enzymes may have different evolutionary origins
based on the phylogeny individually performed for SFP-PPT,
ACPS-PPT, and hydrolase protein sequences. Apicomplexan
SFP-PPTs are phylogenetically related to animal and some
FIG. 2. Comparison of two types of PPTases among apicomplexans and other groups of organisms. SFP-PPTs are present in bacteria, type I
FAS-containing apicomplexans, fungi, animals, and plants. Some plant SFP-PPTs may contain an N-terminal mitochondrium-targeting signal
(open box in parenthesis). ACPS-PPTs are present in bacteria, plastid-containing apicomplexans, and fungi. Apicomplexan ACPS-PPTs are
bifunctional and contain plastid-targeting signals (open box). Fungal ACPS-PPTs are present as a C-terminal domain in the -subunit of fatty acid
synthase (FAS2). PSSM logos include two motifs for all PPTases, one specific to SFPs and one for hydrolases.
TABLE 1. Correlation between the types of PPTases and FAS/PKS in apicomplexans
Organism Type of FAS/PKS PPTasea Signal peptidein PPTases
Prediction method
PlasmoAPb ChloroPc PlasMitd
P. falciparum Type II FAS PfACPS-PPT Plastid Yes No Nof
C. parvum Type I FAS and PKS CpSFP-PPT No No No Nof
T. gondii Type II FAS TgACPS-PPT Plastid No
e Yes Nof
Type I FAS TgSFP-PPT No No No Nof
a Sources of apicomplexan PPTase protein sequences: CpSFP-PPT (GenBank accession no. AY856092) was annotated from cDNA in this study; PfACPS-PPT
(NP_702851) was identified in GenBank by BLAST searches; TgSFP-PPT (contig TGG_995284) and TgACPS-PPT (TgTwinScan_3790) were identified from raw
genome sequences at ToxoDB, release 3.0 (http://www.toxodb.org). Also see the supplemental material for conceptually translated TgSFP-PPT and TgACPS-PPT
sequences.
b http://www.plasmodb.org/restricted/PlasmoAPcgi.shtml.
c http://www.cbs.dtu.dk/services/ChloroP/.
d http://gecco.org.chemie.uni-frankfurt.de/plasmit/.
e PlasmoAP is trained for predicting plastid-targeting sequences in the AT-rich P. falciparum genes and may not be able to accurately predict sequences from other
species including T. gondii.
f All sequences are predicted to be 99% unlikely to contain mitochondrium-targeting signals.
1214 CAI ET AL. EUKARYOT. CELL
 at Penn State Univ on February 12, 2008 
e
c.a
sm
.o
rg
D
ow
nloaded from
 
fungal PPTases in maximum-likelihood trees inferred from 30
closely related protein sequences (Fig. 3A). The animals plus
apicomplexans plus fungi cluster was subsequently joined by a
group of 
-proteobacteria. It is noted that plants and some
fungi formed two clades separated from the animal clade (Fig.
3A). However, because the resolving power of the SFP-PPT
data set was limited by the small number of alignable positions
(i.e., 52 amino acids), one could not firmly determine whether
the separation among eukaryotic SFP-PPTs (more intriguingly,
the separation of different fungal sequences) is caused by the
long branch attraction artifact or indeed a result of multiple
evolutionary origins of these eukaryotic SFP-PPTs.
On the other hand, apicomplexan ACPS-PPTs are more
closely related to bacterial PPTases. ML phylogeny based on
30 protein sequences placed PfACPS-PPT and TgACPS-PPT
within the -proteobacterial cluster (Fig. 3B). The proteobac-
terial origin of apicomplexan ACPS-PPTs was further sup-
ported by the phylogenetic analysis of the hydrolase domains,
in which the apicomplexan clade formed a sister group to the
-, -, and 
-proteobacterial clade (though paraphyletic to the
-proteobacterial hydrolases) (Fig. 3C).
The unusual two-intron-containing CpSFP-PPT gene is ex-
pressed in all parasite life cycle stages. Among apicomplexan
PPTase genes, PfACPS-PPT (NP_702851) has recently been
annotated by the P. falciparum genome-sequencing consor-
tium. TgACPS-PPT (TgTwinScan_3790) and TgSFP-PPT (con-
tig TGG_995284) were identified from the ToxoDB (Release
3.0; 10 coverage) raw genome sequence data (http://www
.toxodb.org) (see TgSFP-PPT and TgACPS-PPT protein se-
quences in the supplemental material). CpSFP-PPT has been
annotated by the C. parvum genome project (EAK89734) as an
intronless gene. However, our sequence analysis of CpSFP-
PPT cDNA indicated that this gene is actually interrupted by
two introns. The first intron contains multiple stop codons in
FIG. 4. Western blot detection of CpSFP-PPT in total protein ex-
tracted from C. parvum sporozoites using a rabbit polyclonal antibody
against a synthetic peptide specific to CpSFP-PPT. The negative con-
trol used rabbit preimmune serum.
FIG. 3. ML trees inferred from (A) SFP-PPT sequences (30 se-
quences, 52 positions; lnL  2132.5); (B) ACPS-PPT sequences (30
sequences, 83 positions; lnL  3327.5); and (C) metal-dependent
hydrolase sequences (32 sequences, 88 positions; lnL  4264.4).
Statistical supporting values are posterior probabilities based on a
Bayesian inference method. Only posterior probability values of70%
are shown, and solid dots represent PP values of 95%.
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all three open reading frames. However, the second intron is
cryptic, since it contains no stop codon in the open reading
frame extended from the second exon, thus misleading the
computational prediction of C-terminal amino acids. Introns
are not common in C. parvum, and only a few of them are
reported (6, 7, 9). The genome-wide analysis suggests that only
	5% of C. parvum genes may contain introns (2). Therefore,
the presence of two introns in CpSFP-PPT appears to be un-
usual for this parasite.
In Western blotting analysis of fractionated proteins from C.
parvum sporozoites, the rabbit anti-CpSFP-PPT antibodies
recognized a major band at 	37 kDa (Fig. 4), although a
slightly higher minor band (probably caused by nonspecific
reactions) was also observed. The detected molecular weight
agrees well with the theoretical mass of the CpSFP-PPT pro-
tein. Real-time qRT-PCR analysis indicated that the CpSFP-
PPT gene is expressed in all C. parvum life cycle stages, sug-
gesting that the activation of ACP domains is a continuous
process during parasite development. However, the relative
level of CpSFP-PPT transcripts (normalized using the level of
18S rRNA) was slightly higher in sporozoites and intracellular
parasites at 12 h postinfection than other stages (Fig. 5). The
lowest level of CpSFP-PPT expression was in the oocysts, and
correlated with the overall low metabolic activity in this envi-
ronmental parasite stage (Fig. 5). The low-level expression of
CpSFP-PPT in unexcysted oocysts is unlikely to be an experi-
mental artifact caused by poor isolation of oocyst RNA, be-
cause a comparable level of 18S rRNA was detected from this
sample. The CpSFP-PPT protein was also detected in the cy-
tosol of all parasite life cycle stages by indirect immunofluo-
rescence microscopy (Fig. 6), which agrees with the lack of any
signal peptide sequence and is congruent with the cytosolic
nature of its substrates (CpFAS1 and CpPKS1) (44).
CpSFP-PPT is capable of activating CpFAS1 ACP domains
in vitro or when coexpressed in E. coli. The S-tag-fused
CpSFP-PPT protein was successfully expressed from a syn-
thetic gene in bacteria. Using an S-protein-based affinity puri-
fication procedure, the “native” CpSFP-PPT portion was
cleaved from the S tag and purified to homogeneity (Fig. 7A,
inset). Radiochemical assays revealed that like human PPTases
(19), CpSFP-PPT is able to utilize both CoA and acetyl-CoA as
substrates for transferring the phosphopantetheine moiety to
recombinant T7-CpACP1 and MBP-CpACP2 proteins. The
activity of CpSFP-PPT is Mg2 dependent and can be inhib-
ited by EDTA (Fig. 7A). However, the optimal Mg2 concen-
tration for CpSFP-PPT (0.1 to 1 mM) differs dramatically from
that for the human PPTase (5 to 20 mM) (19). Furthermore,
although Mg2 at low concentrations could cooperatively ac-
tivate CpSFP-PPT, it also inhibited enzyme activity at higher-
FIG. 5. Relative transcriptional levels of the CpSFP-PPT gene
among various C. parvum developmental stages as determined by real-
time quantitative RT-PCR. The amount of CpSFP-PPT transcript in
each sample was first normalized with that of 18S rRNA. The relative
levels of transcripts in all samples were then expressed by comparing
their normalized values with the mean value.
FIG. 6. Indirect immunofluorescence microscopic detection of CpSFP-PPT in C. parvum free sporozoites (Spz) and an intracellular develop-
mental stage (a merozoite-containing meront) cultured in HCT-8 cells for 24 h. Samples were labeled with rabbit polyclonal antibody to
CpSFP-PPT and TRITC-conjugated antirabbit immunoglobulin G monoclonal antibody that gave a diffused pattern in the cytosol of all samples.
Preimmune serum did not label the parasite (data not shown). The nuclei were counterstained with 4,6-diamidino-2-phenylindole (DAPI).
Parasite morphology is shown as differential interference constrast (DIC) images taken from the same microscopic fields. A similar pattern of
cytosolic distribution of CpSFP-PPT was observed in other intracellular stages (e.g., 12 to 72 h postinfection) but is not shown here.
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than-optimal concentrations (Fig. 7B). The detrimental effect
of Mg2 at higher-than-optimal concentrations has not been
reported for other PPTases. However, such an “inhibitory ef-
fect” of a metal cofactor at high concentrations has been re-
ported for other Mg2-dependent enzymes, e.g., the smooth
muscle myosin phosphatase and some rubber transferases (33,
35). In the latter case, it was speculated that metal, substrate,
and metal-substrate complex could independently bind to the
enzyme active site with different affinities. At low Mg2 con-
centrations, metal predominantly bound to substrate, thus ac-
tivating metal-dependent enzyme activity. However, when
Mg2 concentrations reached too high, it started to compete
with the substrate for the active site, thus inhibiting the enzyme
activity (35).
In the absence of Mg2, CpSFP-PPT might utilize Mn2 or
Zn2 (albeit with much lower enzymatic activities) but not
Ca2 (Fig. 7A). Using [1-14C]acetyl-CoA as a substrate and
MBP-CpACP2 as a cosubstrate, the Vmax of CpSFP-PPT was
determined as 44.1 (0.675) nmol · mg1 · min1 (Fig. 7C),
which is much lower than the reported Vmax values for human
PPTase using human FAS ACP (288 nmol · mg1 · min1) or
mitochondrial ACP (186 nmol · mg1 · min1) as cosubstrates
(19). The Km was 4.9 (0.325) M (Fig. 7C), which is compa-
rable to those of humans (3.1 to 7.5 M). The Kcat (	1.6
min1) and Kcat/Km (0.324 min
1 · M1) were at the low end
among the PPTases reported so far (19, 25, 26).
The successful transfer of a phosphopantetheine moiety
from both acetyl-CoA and CoA to T7-CpACP1 was ultimately
confirmed by three different approaches. The presence of a
phosphopantetheinyl moiety in holo-ACP proteins was made
evident by the differences in molecular masses between holo-
and apo-ACP proteins as determined by MALDI-TOF MS
analysis (Table 2; Fig. 8A and B) and SDS-PAGE fractionation
(Fig. 8C). Radioactive phosphopantetheinyl moieties trans-
ferred from acetyl-CoA were detected in T7-CpACP1 and
MBP-ACP2 fusion proteins that were treated with CpSFP-PPT
by autoradiography but not in the proteins that received no
CpSFP-PPT treatment (Fig. 8D).
In addition, we also tested whether S-tag-fused CpSFP-PPT
could activate T7-CpACP1 by coexpressing both proteins in
bacteria. When the T7-CpACP1 protein coexpressed with S-
CpSFP-PPT in bacteria was affinity purified and subjected to
MALDI-TOF MS analysis, we observed that approximately
78% of the protein was present in holo form (Table 2; Fig. 8A
and B). This observation suggests that S-CpSFP-PPT is not
100% efficient in activating coexpressed T7-CpACP1 in bacte-
rial cells, probably due to the limited supply of CoA and acetyl-
CoA in bacterial cells.
FIG. 7. Enzymatic activity of recombinant CpSFP-PPT using
[1-14C]acetyl-CoA and MBP-CpACP2 as cosubstrates. (A) Effects of
cations (1.0 mM each) on the CpSFP-PPT activities. Inset shows the
purified CpSFP-PPT (without S tag) analyzed by SDS-PAGE. (B) Ef-
fects of Mg2 concentrations on the activity of CpSFP-PPT. (C) En-
zyme kinetics of CpSFP-PPT determined using various concentrations
of [1-14C]acetyl-CoA and 5.0 M MBP-CpACP2 as cosubstrates. Note:
In all samples, bars represent standard-error-of-the-mean values de-
rived from at least three replicated reactions. The data presented here
were generated from at least two independent experiments.
TABLE 2. Determination of molecular masses of recombinant T7-
CpACP1 by MALDI-TOF MSa
Preparation of T7-CpACP1 Theoreticalmass (Da)
Determined
mass (Da)
Treated with CoA and Acetyl-CoA, but
without CpSFP-PPT
13,066 13,060
Treated with CoA and CpSFP-PPT 13,405 13,400
Treated with acetyl-CoA and CpSFP-PPT 13,448 13,484b
Untreated, isolated from bacteria with
plain pRARE vector only
13,065 13,061
Untreated, isolated from bacteria co-
expressed with CpSFP-PPT
13,405 13,007 (22%)
13,470 (78%)c
a The 339-Da (or 382-Da) difference between apo- and holo-ACP following
modification by CpSFP-PPT is due to the transferred phosphopantetheinyl moi-
ety from CoA (or acetyl-CoA).
b The discrepancy between theoretical and determined mass (36 Da) is
probably caused by the N acetylation or carbamoylation of T7-CpACP1 as
described for human ACP (19).
c About 78% of the T7-CpACP1 coexpressed with CpSFP-PPT is in holo form
(also see Fig. 8A and B for the mass spectrometry profiles). The discrepancy
between theoretical and determined masses (65 Da) here indicates that a fatty
acyl group is probably added to the holo-CpACP1, a phenomenon that has also
been described for the bacterially expressed P. falciparum type II ACP (41).
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DISCUSSION
Apicomplexan parasites differ from their human and animal
hosts in fatty acid synthesis by possessing either a type II
pathway for de novo synthesis of long-chain fatty acids (e.g., P.
falciparum) (32, 40, 41) or uniquely organized type I FAS for
making very long chain fatty acids from long-chain fatty acids
(e.g., C. parvum) (42, 44) or both (e.g., T. gondii and E. tenella)
(8). The ACP proteins can be either discrete monofunctional
enzymes in a type II pathway or functional domains fused
within multifunctional FASs or PKSs. The types of PPTase
present in an apicomplexan correlated well with the types of
FASs possessed by the organism (Table 1), which supports the
hypothesis that two distinct PPTases may be responsible for
the activation of two different types of ACP in apicomplexans:
the SFP-PPTs for type I ACP domains and the ACPS-PPTs for
type II ACP enzymes.
The two types of apicomplexan PPTases appear to have
different evolutionary origins: the SFP-PPTs in C. parvum and
T. gondii are closely related to animal and fungal PPTases (Fig.
3A), whereas the ACPS-PPTs in P. falciparum and T. gondii are
bacterium-like, probably having been acquired from a pro-
teobacterial ancestor (Fig. 3B and C). The presence of two
conserved motifs in both ACPS-PPT and SFP-PPT indicates
that the two types of PPTases must have evolved from a com-
mon ancestor. The separation between ACPS-PPT and SFP-
PPT might have occurred before the emergence of eukaryotes,
based on the fact that prokaryotic and eukaryotic sequences
are intermixed in both SFP-PPT and ACPS-PPT trees. In ad-
dition, apicomplexan SFP-PPTs appear to be more ancient
than ACPS-PPTs, since the former (clustered with animals and
fungi) were likely eukaryotic descendants, while the latter (bac-
terium-like) were probably acquired from a proteobacterium
by lateral gene transfer after the Apicomplexa diverged from
other eukaryotes.
The ability to obtain holo-ACP is critical to the biochemical
and pharmaceutical studies of FASs. Bacterial expression sys-
tems are commonly used in producing recombinant apicompl-
exan proteins for functional analysis. Previous studies have
FIG. 8. Detection of the phosphopantetheinyl moiety from CpSFP-PPT-activated CpFAS1 ACP domains. (A) MALDI-TOF mass spectrum of
T7-CpACP1 expressed in bacteria. A single peak at 12,061 Da indicates that all C. parvum T7-CpACP1 proteins were present in apo form.
(B) MALDI-TOF mass spectrum of T7-CpACP1 coexpressed with CpSFP-PPT in bacteria. The major peak at 13,471 Da represents holo-T7-
CpACP1 (	78%), while the minor peak with lower molecular mass represents apo-T7-CpACP1 (	22%). (C) Differentiation between apo- and
holo-CpACP1 by SDS-PAGE (20% gel) stained with Coomassie blue. Apo-T7-CpACP1 (lanes 1, 3) migrated slightly faster than holo-T7-CpACP1
that received a phosphopantetheinyl moiety from CoA (lane 2) or acetyl-CoA (lane 4) after CpSFP-PPT treatment. (D) CpSFP-PPT-catalyzed
transfer of a phosphopantetheinyl moiety from [1-14C]acetyl-CoA (included in all reactions) to either T7-CpACP1 (lane 3) or MBP-CpACP2 (lane
4) was detected by autoradiography. No radioactivity was detected from these two proteins receiving no CpSFP-PPT treatment (lanes 1 and 2) or
from CpSFP-PPT itself (lane 5).
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shown that recombinant P. falciparum ACP enzymes are
mostly in holo form when expressed in E. coli, suggesting
bacterial ACPS is capable of activating apicomplexan type II
ACP (41). In our previous studies, the 900-kDa CpFAS1 pro-
tein has been successfully expressed in bacteria as five individ-
ual modules (44). However, the ACP domains were found to
be apoenzymes, suggesting that the E. coli ACPS was unable to
activate the parasite ACP during expression. This technical
obstacle apparently has limited our ability in functional dissec-
tion of the unique type I CpFAS1 and CpPKS1 using recom-
binant proteins. Therefore, the discovery and expression of a
functional CpSFP-PPT enzyme clearly indicates that recombi-
nant parasite ACP domains could be activated by CpSFP-PPT,
thus clearing the path for the future functional analyses, in-
cluding the determination of the final product(s), of CpFAS1
and CpPKS1 using recombinant proteins.
Fatty acid synthesis has recently been explored as a novel
drug target (14, 32, 40, 42). The ultimate dependency of both
type I and II FAS (and PKS) on PPTases for synthesizing
holo-ACP, together with the high sequence divergence be-
tween apicomplexan and animal PPTases, indicates that PPTa-
ses may be explored as promising drug targets for this group of
globally important parasites.
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